With a blockbuster IPO on the horizon, Australian biotech innovation is drawing global eyes and fresh capital to …
With a blockbuster IPO on the horizon, Australian biotech innovation is drawing global eyes and fresh capital to …
A new multinational clinical trial marks a significant step in developing transformative gene therapies for rare inherited disorders.
New partnerships and funding rounds are powering the rapid growth of RNA therapeutics.
Moderna pushes the boundaries of mRNA therapy into rare genetic diseases, aiming for transformative treatments.
AI-driven drug discovery is accelerating innovation and transforming biopharma R&D.
Australia’s National Genomic Registry is connecting patients, clinicians, and researchers to transform rare disease care in real time.
Australian-led clinical trials are advancing the future of diabetes care with oral insulin innovations.
New partnerships in real-time genomics promise faster, more accurate diagnoses for pediatric rare diseases.
New device approval and robust oncology funding highlight ongoing biopharma momentum in cancer therapies.
A promising vaccine candidate advances efforts to combat neglected tropical diseases with mRNA innovation.
Already a subscriber? Log in